Zhang X, Wyss U P, Pichora D, Goosen M F
Department of Chemical Engineering, Queen's University, Kingston, Ontario, Canada.
J Pharm Pharmacol. 1994 Sep;46(9):718-24. doi: 10.1111/j.2042-7158.1994.tb03890.x.
Controlled antibiotic release films, melt-extruded cylinders, and suspension-extruded/coated cylinders were manufactured from biodegradable poly(D,L-lactide) (PDLLA) and poly(D,L-lactide-co-epsilon-caprolactone). These devices have potential application in the treatment of osteomyelitis. The in-vitro release properties of the devices were examined with drug loadings varying from 16 to 50%. Gentamicin sulphate films and melt-extruded gentamicin/PDLLA cylinders demonstrated a large initial burst and incomplete release. The films and melt-extruded cylinders made from poly(D,L-lactide-co-epsilon-caprolactone), low mol. wt poly(D,L-lactide), and a mixture of D,L-lactic acid oligomer and high mol. wt poly(D,L-lactide), did not remain intact during the entire release period. While this is undesirable, these materials do have the advantage of not requiring a processing temperature of greater than 110 degrees C. Antibiotic release from high mol. wt PDLLA-coated gentamicin/PDLLA cylinders, with 40 and 50% loading, was very rapid. The antibiotic could only diffuse out through the open ends of the cylinder. Coated gentamicin sulphate cylinders with 20 and 30% drug loading gave the most promising properties in terms of a small initial burst, and a gradual and sustained release. The release rate and duration from the coated cylinders could be adjusted by cutting the cylinder into different lengths; the time required for 90% of the entrapped gentamicin to be released into water from 30% loaded PDLLA-coated cylinders 0.2, 0.4, 0.7 and 1 cm in length was 1000, 1700, 2300, and 2800 h, respectively. This offers a convenient method to adjust the release to meet the specific antibiotic requirement of different patients.(ABSTRACT TRUNCATED AT 250 WORDS)
可控抗生素释放薄膜、熔融挤出圆柱体以及悬浮挤出/涂层圆柱体由可生物降解的聚(D,L-丙交酯)(PDLLA)和聚(D,L-丙交酯-共-ε-己内酯)制成。这些装置在骨髓炎治疗中具有潜在应用价值。对药物负载量在16%至50%之间变化的这些装置的体外释放特性进行了研究。硫酸庆大霉素薄膜和熔融挤出的庆大霉素/PDLLA圆柱体表现出较大的初始突释和不完全释放。由聚(D,L-丙交酯-共-ε-己内酯)、低分子量聚(D,L-丙交酯)以及D,L-乳酸低聚物和高分子量聚(D,L-丙交酯)的混合物制成的薄膜和熔融挤出圆柱体在整个释放期间并未保持完整。虽然这并不理想,但这些材料具有不需要高于110摄氏度的加工温度的优点。从负载量为40%和50%的高分子量PDLLA涂层的庆大霉素/PDLLA圆柱体中释放抗生素非常迅速。抗生素只能通过圆柱体的开口端扩散出去。负载量为20%和30%的涂层硫酸庆大霉素圆柱体在初始突释小、释放逐渐且持续方面表现出最有前景的特性。涂层圆柱体的释放速率和持续时间可以通过将圆柱体切成不同长度来调节;从长度为0.2厘米、0.4厘米、0.7厘米和1厘米、负载量为30%的PDLLA涂层圆柱体中将90%包封的庆大霉素释放到水中所需的时间分别为1000小时、1700小时、2300小时和2800小时。这提供了一种方便的方法来调节释放,以满足不同患者对抗生素的特定需求。(摘要截短至250字)